The Penumbra JET 7 and Penumbra JET D reperfusion catheters are no commercially available in the US, manufactured by and available from Penumbra (Alameda, CA). Both catheters are powered by the Penumbra ENGINE aspiration source aspiration-based mechanical thrombectomy for stroke revascularization.
The JET D is designed for aspiration of distal clots, whereas the JET 7 is for large vessel occlusions (LVOs) and both permit safe and effective thrombus extraction in patients with acute ischemic stroke.
The JET 7 has a large 0.072 in lumen for deep-vacuum aspiration, trackability, and navigation including 20 positional transitions along the catheter with a progressive distal coil wind for flexibility and quad-wire technology for enhanced pushability.
“The JET 7 Reperfusion Catheter with its advanced tracking technology and large 0.072 inch aspiration lumen is the most advanced device for stroke. In my clinical experience, I was able to easily and quickly navigate the JET 7 through tortuous anatomy to the face of the clot and achieve full revascularization after a single pass,” said Alejandro M. Spiotta, MD, Medical University of South Carolina, Charleston, S.C. “We know from our own published experience that increases in aspiration lumen size have led to faster recanalization times and higher likelihood of success at first pass without compromising safety. I eagerly await collecting and publishing our clinical experience with JET 7.”
“The JET 7 and JET D along with the new ENGINE provide a suite of tools to effectively address both proximal and distal occlusions,” said Ian Kaminsky, MD, MS, Radiology Imaging Associates/Swedish Medical Center, Englewood, Colorado. “In our initial case experience, we saw the easy tracking of the JET 7 and JET D in a range of tortuous conditions and vessel locations that, combined with the deep vacuum of the ENGINE, offer the potential to increase our rate of complete first pass revascularization while decreasing procedure times.”Next Story